Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg).

E. Krauss (Giessen, Germany), S. Tello (Giessen, Germany), R. Dartsch (Giessen, Germany), M. Korfei (Giessen, Germany), P. Mahavadi (Giessen, Germany), M. Stoehr (Giessen, Germany), J. Wilhelm (Giessen, Germany), R. Majeed (Giessen, Germany), P. Bonniaud (Dijon, France), C. Vancheri (Catania, Italy), A. Wells (London, United Kingdom), W. Seeger (Giessen, Germany), B. Crestani (Paris, France), A. Guenther (Giessen, Germany)

Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session: Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session type: E-poster session
Number: 1849

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Krauss (Giessen, Germany), S. Tello (Giessen, Germany), R. Dartsch (Giessen, Germany), M. Korfei (Giessen, Germany), P. Mahavadi (Giessen, Germany), M. Stoehr (Giessen, Germany), J. Wilhelm (Giessen, Germany), R. Majeed (Giessen, Germany), P. Bonniaud (Dijon, France), C. Vancheri (Catania, Italy), A. Wells (London, United Kingdom), W. Seeger (Giessen, Germany), B. Crestani (Paris, France), A. Guenther (Giessen, Germany). Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg).. 1849

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: